Profile: Haemachem, Inc. provides heparin assay. We manufacture medicinal chemicals and biological products. Our heptest kit for quantifying heparin in plasma, is based on hepann-mediated inhibition of factor Xa, resulting in prolongation of clotting time. Our heparin therapy avoids inadequate antithrombotic treatment and bleeding complications. Heparinization is usually accompanied by therapy with oral anticoagulant for long-term treatment after the cessation of heparin therapy.
3 Products/Services (Click for related suppliers)
|
| • Heparin Assay (FDA Code: KFF / 864.7525) A heparin assay is a device used to determine the level of the anticoagulant heparin in the patient's circulation. These assays are quantitative clotting time procedures using the effect of heparin on activated coagulation factor X (Stuart factor) or procedures based on the neutralization of heparin by protamine sulfate (a protein that neutralizes heparin). |
| • Qualitative and Quantitative Factor Deficiency Test (FDA Code: GGP / 864.7290) A factor deficiency test is a device used to diagnose specific coagulation defects, to monitor certain types of therapy, to detect coagulation inhibitors, and to detect a carrier state (a person carrying both a recessive gene for a coagulation factor deficiency such as hemophilia and the corresponding normal gene). |
| • Thrombin Time Test (FDA Code: GJA / 864.7875) A thrombin time test is a device used to measure fibrinogen concentration and detect fibrin or fibrinogen split products for the evaluation of bleeding disorders. |